全文获取类型
收费全文 | 582篇 |
免费 | 41篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 30篇 |
妇产科学 | 2篇 |
基础医学 | 43篇 |
口腔科学 | 17篇 |
临床医学 | 42篇 |
内科学 | 177篇 |
皮肤病学 | 3篇 |
神经病学 | 10篇 |
特种医学 | 25篇 |
外科学 | 231篇 |
预防医学 | 3篇 |
眼科学 | 6篇 |
药学 | 12篇 |
中国医学 | 2篇 |
肿瘤学 | 22篇 |
出版年
2023年 | 4篇 |
2022年 | 11篇 |
2021年 | 18篇 |
2020年 | 8篇 |
2019年 | 13篇 |
2018年 | 18篇 |
2017年 | 24篇 |
2016年 | 31篇 |
2015年 | 21篇 |
2014年 | 28篇 |
2013年 | 35篇 |
2012年 | 43篇 |
2011年 | 56篇 |
2010年 | 29篇 |
2009年 | 21篇 |
2008年 | 35篇 |
2007年 | 31篇 |
2006年 | 17篇 |
2005年 | 14篇 |
2004年 | 24篇 |
2003年 | 20篇 |
2002年 | 32篇 |
2001年 | 9篇 |
2000年 | 6篇 |
1999年 | 9篇 |
1998年 | 6篇 |
1997年 | 12篇 |
1996年 | 3篇 |
1993年 | 4篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1983年 | 3篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 4篇 |
1972年 | 4篇 |
1971年 | 1篇 |
1970年 | 2篇 |
1969年 | 1篇 |
1966年 | 3篇 |
排序方式: 共有625条查询结果,搜索用时 0 毫秒
1.
Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis 总被引:4,自引:0,他引:4
Kosaku Nitta Shigeru Horita Kazuho Honda Keiko Uchida Teruo Watanabe Hiroshi Nihei M. Nagata 《Virchows Archiv : an international journal of pathology》1999,435(4):422-427
To elucidate the mechanism underlying crescentic formation, we assessed the phenotypic characterization and cell-cycle protein expression in human crescentic glomerulonephritis (CRGN). Kidney tissue specimens taken from CRGN patients (10 patients with pauci-immune type rapidly progressive glomerulonephritis (RPGN), 2 patients with Henoch-Schönlein purpura nephritis, and 1 patient with IgA nephropathy) were examined immunohistochemically. Most of the cellular components of the crescents expressed cytokeratin, whereas few cells expressed PHM-5. CD68-positive cells were minor components of cellular crescents, indicating that the major principal cellular component of the crescents is made up of cells with the parietal glomerular epithelial cell (PEC) phenotype. Additionally, serial section analysis revealed that Ki-67-positive cells in the crescents were frequently cyclin-A positive and Bcl-2 positive, but seldom cyclin-B1 positive. Moreover, the expression of cyclin-dependent kinase inhibitor p27Kip1 was low in the cellular crescents, despite being exclusively positive in podocytes within the same section. We concluded that the major component of the cellular crescents is made up of PECs and that apparent expression of cyclins and Bcl-2 and restrained expression of p27Kip1 may be synergistically associated with the development of cellular crescents in human CRGN. 相似文献
2.
An 11-year-old girl with osteosarcoma in the left distal femur, developed unilateral spontaneous pneumothorax. Pneumothorax
was found at the initial presentation, but chest CT failed to reveal pulmonary metastases, bullae or blebs.
Accepted: 7 October 1999 相似文献
Résumé Une fillette de 11 ans présentant un ostéosarcome de la région distale du fémur, chez qui est apparu un pneumothorax spontané. Le pneumothorax a été constatéà la première visite, mais la tomographie par reconstruction d’image n’a permis de révéler ni métastases pulmonaires, ni bulles pulmonaires ou sous-pleurales.
Accepted: 7 October 1999 相似文献
3.
Nakata S Takahashi H Takezawa Y Kobayashi M Matumoto K Kosaku N Kawashima K 《Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology》2000,91(7-8):584-588
PURPOSE: The PSA level of prostate cancer patients generally declines after endocrine therapy, but elevates when the cancer relapses in most cases. However, the rate of elevation differs with the case. We investigated the PSA doubling time (PSA-DT) of the prostate cancer patients whose PSA declined after endocrine therapy and later re-elevated, and investigated the relationship with other parameters. PATIENTS AND METHODS: We investigated 55 prostate cancer patients who underwent endocrine therapy between 1991 and 1998. Their PSA re-elevated continuously after their PSA fell below 10 ng/ml after the endocrine therapy as the first line treatment. First, the correlation coefficients with time and PSA were calculated in order to decide whether their PSA elevation was exponential or linear. PSA-DT was calculated thereafter, and compared with the clinical stage, pathological differentiation, clinical relapse style, time from the beginning of the therapy to PSA relapse, pre-treatment PSA value, and prognosis. The relationship between PSA-DT and each clinical parameter was tested using the Kruskal-Wallis test. Differences in survival rates and PSA-DT were calculated using the log-rank test. RESULTS: PSA elevated exponentially after cancer relapsed. PSA-DT in all cases ranged from 0.5 to 26.3 months, with an average of 4.4 +/- 4.8 (S.D.) months and the median was 2.5 months. PSA-DT was significantly (p < 0.01) short when the pre-treatment clinical stage was high, the time from the beginning of the therapy to PSA relapse was short, or the pre-treatment PSA value was high. PSA-DT tended to be short when the pre-treatment pathological differentiation was low, but not significantly. PSA-DT tended to be short when the cancer relapsed as distant metastasis rather than regional relapse, but not significantly. Prognosis from the initial treatment and PSA relapse was significantly poor when the PSA-DT was short. CONCLUSIONS: PSA elevated exponentially in the relapsed prostate cancer patients after the endocrine therapy. PSA-DT was distributed in a very wide range, and this value was considered to reflect the malignant potential and prognosis of the cancer. PSA-DT may be useful for determining the strategy after relapse. 相似文献
4.
We report on a rare manifestation of Erdheim-Chester disease with intramuscular lipogranuloma. The patient was a 66-year-old
man who noted a soft tissue mass in the right quadriceps femoris muscle. Radiographs revealed symmetrical osteosclerosis in
the diametaphysis of both femora and tibiae. An open biopsy revealed a proliferation of lipid-laden histiocytes in the femoral
bone marrow and the quadriceps femoris muscle. To our knowledge, this is the second case of Erdheim-Chester disease involving
muscle.
Received: 4 October 1999 Revision requested: 18 November 1999 Revision received: 1 December 1999 Accepted: 2 December 1999 相似文献
5.
6.
Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication 下载免费PDF全文
7.
8.
Otsubo S Tanabe K Shinmura H Ishikawa N Tokumoto T Hattori M Ito K Nitta K Akiba T Nihei H Toma H 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2004,8(4):299-304
In the present study, we reviewed the effect of post-transplant double filtration plasmapheresis (DFPP) on recurrent focal segmental glomerulosclerosis (FSGS) in the transplanted kidney allograft. Sixteen patients with post-transplant recurrent FSGS were enrolled in this study. Out of 16 patients with recurrent FSGS after transplantation, five did not receive DFPP and lost their grafts, while 11 did receive DFPP and four of these patients lost their grafts. Seven patients were able to maintain normal renal function for an average observation period of 57.1 +/- 40.7 months (range 7-125 months). In five patients who had a significant reduction in urinary protein after DFPP, the urinary protein level decreased from 26.60 +/- 23.05 g/day (range 3.34-62.6 g/day) to 2.95 +/- 3.42 g/day (range 0.02-8.64 g/day) and renal function was maintained. The beneficial effects of DFPP on graft outcome were more likely to occur if the patients experienced a marked drop in urinary excretion. Thus, post-transplant DFPP appears to be effective for reducing urinary protein levels and improving long-term graft survival. With the small numbers in this trial, however, none of the findings were statistically significant. We recommend the use of post-transplant DFPP to prevent the progression of recurrent FSGS. 相似文献
9.
Enyu Imai Seiichi Matsuo Hirofumi Makino Tsuyoshi Watanabe Tadao Akizawa Kosaku Nitta Satoshi Iimuro Yasuo Ohashi Akira Hishida 《Hypertension research》2008,31(6):1101-1107
The prevalence and incidence of end-stage renal disease (ESRD) in Japan are the highest and the third highest, respectively, in the world, while the incidence of cardiac death in Japan is the lowest among developed countries. A recent study showed that the prevalence of chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m(2), is extremely high in Japan, about 20% of the adult population. However, the risk of ESRD and cardiovascular disease (CVD) in the CKD population has not been determined nationwide. For this observational study, we will establish a Chronic Kidney Disease Japan Cohort (CKD-JAC) by enrolling 3,000 patients with CKD in 17 clinical centers around Japan, which will be used to determine the incidence of ESRD and CVD in Japanese CKD patients. Risk factors associated with the development of CVD will also be examined. Comorbidity of diabetes in CKD patients will be analyzed to determine whether it is a risk for rapid progression of CKD and high incidence of CVD. In addition, we will study whether the burden of CKD decreases the QOL of patients, and increases hospitalization or health resource utilization. Insights from the CKD-JAC study will provide a basis for future interventional trials focused on reducing the burden of ESRD and CVD in patients with CKD in Japan. 相似文献
10.
Anri Sawada Masayoshi Okumi Shigeru Horita Tomomi Tamura Sekiko Taneda Hideki Ishida Motoshi Hattori Kazunari Tanabe Kosaku Nitta Kazuho Honda Junki Koike Yoji Nagashima Akira Shimizu 《Pathology international》2021,71(6):406-414
Monoclonal tubular basement membrane immune deposits (TBMID) are associated with progression of interstitial injury in renal allograft. However, the significance of monoclonal and polyclonal TBMID in the native kidney remains unclear. We retrospectively analyzed 1894 native kidney biopsies and 1724 zero-hour biopsies performed between 2008 and 2018 in our institution. The rate of immunoglobulin G (IgG) TBMID was found to be 8.4% among native kidney biopsies and 0.4% among zero-hour biopsies. Polyclonal TBMID is common in IgG4-related tubulointerstitial nephritis (37.5%), diabetic nephropathy (31.3%) and lupus nephritis (25.5%). Monoclonal IgG TBMID was identified in seven cases, including three zero-hour biopsies. The combination of IgG1κ was observed in two cases, IgG1λ in three, and IgG2κ in two. Electron microscopy revealed powdery electron-dense deposits in all cases. Monoclonal gammopathy of undetermined significance was diagnosed in one case. Although one patient with focal segmental glomerulosclerosis developed renal failure, all others exhibited stable renal function. Monoclonal IgG TBMID in the native kidney is not associated with renal prognosis. However, this may be an interesting immunopathological finding that would help clarify the pathogenesis of TBM immune deposits. Further study for both monoclonal and polyclonal TBMID is required in the future. 相似文献